Skip to main content
Clinical Trials/NCT06762262
NCT06762262
Active, not recruiting
Not Applicable

Effects of Pilate Training Versus Moderate Intensity Continous Training on Dyspnea and Cardiovascular Fitness in Hypertensive Patients

Riphah International University1 site in 1 country52 target enrollmentApril 20, 2024
ConditionsPrehypertension

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Prehypertension
Sponsor
Riphah International University
Enrollment
52
Locations
1
Primary Endpoint
6 MWT
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

Hypertension, commonly known as high blood pressure, continues to be the leading cause of both sickness and mortality globally. Generally, individuals in good health might have trouble breathing solely during vigorous exercise or when holding their breath, finding relief by stopping the activity or adjusting their breathing technique. Often patients with hypertension seek various treatments to relieve symptoms. The aim of this study is to compare the effects of Pilates Training and Moderate Intensity Continuous Training on dyspnea and cardiovascular fitness in hypertensive patients. The study would be randomized clinical trial. A total of thirty-four subjects will be assigned randomly by using block randomization into two groups. Group A will be given Pilates training while Group B will moderate intensity training. After confirmation of diagnosis with medical history and physical examination as well as chronic, mild-to moderate, and stable (>1 year duration) hypertension (systolic blood pressure [SBP] between 140-179 mm Hg and diastolic blood pressure [DBP]between 90-109 mm Hg) recommended. 3-minute step test, VO2max and Modified BORG scale would be used as an outcome measure tools for cardiovascular parameters and dyspnea. The collected data will be analyzed in SPSS 25.0. Descriptive and inferential statistics will be applied after testing normality of data

Registry
clinicaltrials.gov
Start Date
April 20, 2024
End Date
April 30, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Participants must be between 45 to 70 years old
  • Gender: Male and Female both
  • Chronic, mild-to moderate, and stable (\>1 year duration) hypertension (systolic blood pressure
  • \[SBP\] between 140-179 mm Hg and diastolic blood pressure \[DBP\] between 90-109 mm Hg).
  • Single antihypertensive medication will be recruited.
  • Participants have sedentary life style.
  • Smokers, alcoholic, diabetic, and other cardiac problems (controlled) would be included.

Exclusion Criteria

  • Patients with Permanent atrial fibrillation
  • Patients with COPD
  • Patients with Heart surgery
  • Patients with presence of symptomatic congestive heart failure
  • Smokers, alcoholic, diabetic, and other cardiac, renal, and respiratory disease patients (uncontrolled) would be excluded.
  • Participants with no history of psychiatry or psychological disorders or abnormalities.

Outcomes

Primary Outcomes

6 MWT

Time Frame: 8 weeks

VO2 max

Time Frame: 8 weeks

Borg Dyspnea Scale

Time Frame: 8 weeks

Study Sites (1)

Loading locations...

Similar Trials